Wilson Martin 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Wilson Martin
General Counsel
Transactions
- Sale
Common Stock
2025-11-18$2.98/sh−1,646$4,910→ 383,816 total
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.